In clinical trials, the combination injectable Soliqua has demonstrated effective sugar control, without weight gain and with lower risk of hypoglycemia, compared to twice daily premix insulins. Soliqua is a once-daily injectable combination drug containing insulin glargine 100 Units/ml, which is a long-acting basal insulin and lixisenatide, a GLP-1 receptor agonist
Finally, individuals with a history of heart failure, ischaemic heart disease, unstable angina, myocardial infarction, aortic aneurysm or dissection, stroke (ischaemic or haemorrhagic stroke), cerebral infarction, transient ischaemic attack, carotid intervention or surgery, coronary stenting, percutaneous coronary intervention (PCI) or coronary artery bypass before inclusion to the cohort or prior to the index event were also excluded
Ideal para quienes buscan quemar grasa , mejorar el rendimiento y acelerar la recuperacin muscular
Most labs recommend against using any sort of provoking agents before urinary mycotoxin testing (such as charcoal or glutathione) as they may affect the urinary levels of mycotoxins